Background and Aims Despite advances in endoscopic therapies, malignancy-related GI
bleeding remains difficult to manage with high rates of treatment failure and rebleeding …

Background and study aims Hemostatic powders are increasingly used to address
limitations in conventional endoscopic techniques for gastrointestinal bleeding. Various …

Background and study aims Novel topical hemostatic agents have shown promising results
in treating patients with non-variceal upper gastrointestinal bleeding (NVUGIB). However …

Methods We searched Embase, Scopus, Web of Science, Medline/PubMed, and Cochrane.
Inclusion criteria encompassed studies focusing on malignancy-related GI bleeding and …

Hemostatic powder (HP) is a relatively recent addition to the arsenal of hemostatic
endoscopic procedures (HEPs) for gastrointestinal bleeding (GIB) due to benign and …

Regardless of technical advancements, delayed bleeding is still a common adverse event
after gastric endoscopic submucosal dissection (ESD), often occurring in the early …

Background Randomized controlled trials have shown that hemostatic powder (TC-325)
results in greater immediate hemostasis and lower 30-day rebleeding rates than standard …

Can prophylactic argon plasma coagulation reduce delayed post-papillectomy bleeding?
Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds …

Gastrointestinal bleeding secondary to malignancy can be difficult to manage with traditional
endoscopic therapies. Endoscopic suturing is a relatively new technology with limited data …

Background Topical hemostatic powders are a reliable second-line approach in acute
gastrointestinal (GI) bleeding (AGIB) treatment, according to the existing guidelines …